Keita Mori, CEO of SanBio
interviewed by Mornigster CEO, Tomoya Asakura
"Current regenerative therapies and their growth outlook"
Keita Mori, CEO of SanBio presents the Company’s founding vision, development structure and achievements, and business development plan at the interview on June 17, 2017.
Gary Steinberg, MD, PhD
Chair, Dept. of Neurosurgery,
Stanford University School of Medicine - "New Approaches to Improving Lives of Stroke Patients"
SanBio clinical trial results (before/after) can be seen in the first half of the video (2 patients, 2:10-3:35)
*The video shows results of two patients who received regenerative cell medicine SB623 two years post stroke;
a patient who couldn't raise her arm is now able to raise her arm above head; a patient who couldn't move her leg is now able to move the limb, and cautiously even to walk.